Question 1

Which biofilm assay should be used?

Accepted Answer

One matching the claim. Crystal violet measures total attached biomass including matrix and non-viable cells; colony counts measure survivors; imaging measures architecture. A treatment can reduce one and not another, so reporting at least two, and naming which supports each statement, prevents an overstated conclusion.

Question 2

Why is complementation expected for mutants?

Accepted Answer

Because constructing a null mutant can affect more than the intended gene, through polar effects on neighbouring genes or through second-site changes acquired during construction. Restoring the gene and recovering the phenotype is what links the two. A mutant phenotype reported without complementation invites the obvious objection.

Question 3

Are reporter strains sufficient for signal detection?

Accepted Answer

For screening, often. For quantification, less so, since reporters respond to related molecules and their output depends on growth state. Analytical measurement by chromatography alongside a reporter gives concentration rather than relative activity, and the two together are considerably more convincing than either alone.

Question 4

How much do growth conditions matter?

Accepted Answer

A great deal, and they are often underreported. Medium composition, surface material, shear and incubation time all change biofilm quantity and structure substantially. Two laboratories can reach opposite conclusions on the same strain through condition differences, so stating them fully is what makes a result reproducible.

Question 5

Does interfering with signalling avoid resistance?

Accepted Answer

Less reliably than the early framing suggested. Selection still acts where the signalling programme contributes to fitness in the relevant environment, and resistant variants have been described. Treating reduced selective pressure as a hypothesis to test, rather than a property of the approach, is the defensible position.

Question 6

How is virulence connected to the signalling circuit?

Accepted Answer

Through the regulated factors, which need measuring rather than assuming. Showing that a circuit mutant produces less of a factor is one step; showing reduced virulence in an infection model is another. Stating which was demonstrated keeps the claim proportionate to the evidence collected.

Question 7

Should work use a model organism or a clinical strain?

Accepted Answer

Model strains have characterised circuits and available mutants, suiting mechanistic questions. Clinical isolates carry the variation that makes findings relevant but may lack tools and behave differently. Testing a mechanism in the model and then checking it holds in isolates is a common and defensible structure.

Microbiology

Microbiology

Research Frontiers in Quorum Sensing and Bacterial Biofilm Formation